The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Altfeld, M.
Right arrow Articles by Walker, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Altfeld, M.
Right arrow Articles by Walker, B. D.
The Journal of Immunology, 2001, 167: 2743-2752.
Copyright © 2001 by The American Association of Immunologists

Vpr Is Preferentially Targeted by CTL During HIV-1 Infection1

Marcus Altfeld*, Marylyn M. Addo*, Robert L. Eldridge*, Xu G. Yu*,{ddagger}, Seddon Thomas*, Ashok Khatri{dagger}, Daryld Strick*, Mary N. Phillips*, George B. Cohen*, Sabina A. Islam*, Spyros A. Kalams*, Christian Brander*, Philip J. R. Goulder*,§, Eric S. Rosenberg*, Bruce D. Walker2,* and the HIV Study Collaboration,3

* Partners AIDS Research Center and Infectious Disease Division, and {dagger} Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129; {ddagger} AIDS Research Center, First Affiliated Hospital China Medical University, Shenyang, China; § Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, United Kingdom; Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; and || Fenway Community Health Center, Boston, MA 02116

The HIV-1 accessory proteins Vpr, Vpu, and Vif are essential for viral replication, and their cytoplasmic production suggests that they should be processed for recognition by CTLs. However, the extent to which these proteins are targeted in natural infection, as well as precise CTL epitopes within them, remains to be defined. In this study, CTL responses against HIV-1 Vpr, Vpu, and Vif were analyzed in 60 HIV-1-infected individuals and 10 HIV-1-negative controls using overlapping peptides spanning the entire proteins. Peptide-specific IFN-{gamma} production was measured by ELISPOT assay and flow-based intracellular cytokine quantification. HLA class I restriction and cytotoxic activity were confirmed after isolation of peptide-specific CD8+ T cell lines. CD8+ T cell responses against Vpr, Vpu, and Vif were found in 45%, 2%, and 33% of HIV-1-infected individuals, respectively. Multiple CTL epitopes were identified in functionally important regions of HIV-1 Vpr and Vif. Moreover, in infected individuals in whom the breadth of HIV-1-specific responses was assessed comprehensively, Vpr and p17 were the most preferentially targeted proteins per unit length by CD8+ T cells. These data indicate that despite the small size of these proteins Vif and Vpr are frequently targeted by CTL in natural HIV-1 infection and contribute importantly to the total HIV-1-specific CD8+ T cell responses. These findings will be important in evaluating the specificity and breadth of immune responses during acute and chronic infection, and in the design and testing of candidate HIV vaccines.




This article has been cited by other articles:


Home page
J. Virol.Home page
H. Streeck, M. Lichterfeld, G. Alter, A. Meier, N. Teigen, B. Yassine-Diab, H. K. Sidhu, S. Little, A. Kelleher, J.-P. Routy, et al.
Recognition of a Defined Region within p24 Gag by CD8+ T Cells during Primary Human Immunodeficiency Virus Type 1 Infection in Individuals Expressing Protective HLA Class I Alleles
J. Virol., July 15, 2007; 81(14): 7725 - 7731.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
T. Bhattacharya, M. Daniels, D. Heckerman, B. Foley, N. Frahm, C. Kadie, J. Carlson, K. Yusim, B. McMahon, B. Gaschen, et al.
Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations
Science, March 16, 2007; 315(5818): 1583 - 1586.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. Draenert, T. M. Allen, Y. Liu, T. Wrin, C. Chappey, C. L. Verrill, G. Sirera, R. L. Eldridge, M. P. Lahaie, L. Ruiz, et al.
Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus
J. Exp. Med., March 20, 2006; 203(3): 529 - 539.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Wang, B. Metcalf, R. M. Ribeiro, H. McClure, and A. Kaur
Th-1-Type Cytotoxic CD8+ T-Lymphocyte Responses to Simian Immunodeficiency Virus (SIV) Are a Consistent Feature of Natural SIV Infection in Sooty Mangabeys
J. Virol., March 15, 2006; 80(6): 2771 - 2783.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. M. Allen, M. Altfeld, S. C. Geer, E. T. Kalife, C. Moore, K. M. O'Sullivan, I. DeSouza, M. E. Feeney, R. L. Eldridge, E. L. Maier, et al.
Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution
J. Virol., November 1, 2005; 79(21): 13239 - 13249.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Lichterfeld, D. E. Kaufmann, X. G. Yu, S. K. Mui, M. M. Addo, M. N. Johnston, D. Cohen, G. K. Robbins, E. Pae, G. Alter, et al.
Loss of HIV-1-specific CD8+ T Cell Proliferation after Acute HIV-1 Infection and Restoration by Vaccine-induced HIV-1-specific CD4+ T Cells
J. Exp. Med., September 20, 2004; 200(6): 701 - 712.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Lichterfeld, X. G. Yu, M. T. Waring, S. K. Mui, M. N. Johnston, D. Cohen, M. M. Addo, J. Zaunders, G. Alter, E. Pae, et al.
HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-{gamma} and tumor necrosis factor-{alpha}
Blood, July 15, 2004; 104(2): 487 - 494.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. M. Allen, M. Altfeld, X. G. Yu, K. M. O'Sullivan, M. Lichterfeld, S. Le Gall, M. John, B. R. Mothe, P. K. Lee, E. T. Kalife, et al.
Selection, Transmission, and Reversion of an Antigen-Processing Cytotoxic T-Lymphocyte Escape Mutation in Human Immunodeficiency Virus Type 1 Infection
J. Virol., July 1, 2004; 78(13): 7069 - 7078.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. Cardinaud, A. Moris, M. Fevrier, P.-S. Rohrlich, L. Weiss, P. Langlade-Demoyen, F. A. Lemonnier, O. Schwartz, and A. Habel
Identification of Cryptic MHC I-restricted Epitopes Encoded by HIV-1 Alternative Reading Frames
J. Exp. Med., April 19, 2004; 199(8): 1053 - 1063.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Draenert, C. L. Verrill, Y. Tang, T. M. Allen, A. G. Wurcel, M. Boczanowski, A. Lechner, A. Y. Kim, T. Suscovich, N. V. Brown, et al.
Persistent Recognition of Autologous Virus by High-Avidity CD8 T Cells in Chronic, Progressive Human Immunodeficiency Virus Type 1 Infection
J. Virol., January 15, 2004; 78(2): 630 - 641.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ali, S. Pillai, H. Ng, R. Lubong, D. D. Richman, B. D. Jamieson, Y. Ding, M. J. McElrath, J. C. Guatelli, and O. O. Yang
Broadly Increased Sensitivity to Cytotoxic T Lymphocytes Resulting from Nef Epitope Escape Mutations
J. Immunol., October 15, 2003; 171(8): 3999 - 4005.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Corbet, H. V. Nielsen, L. Vinner, S. Lauemoller, D. Therrien, S. Tang, G. Kronborg, L. Mathiesen, P. Chaplin, S. Brunak, et al.
Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes
J. Gen. Virol., September 1, 2003; 84(9): 2409 - 2421.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Altfeld, M. M. Addo, R. Shankarappa, P. K. Lee, T. M. Allen, X. G. Yu, A. Rathod, J. Harlow, K. O'Sullivan, M. N. Johnston, et al.
Enhanced Detection of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses to Highly Variable Regions by Using Peptides Based on Autologous Virus Sequences
J. Virol., July 1, 2003; 77(13): 7330 - 7340.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Meyer-Olson, K. W. Brady, J. T. Blackard, T. M. Allen, S. Islam, N. H. Shoukry, K. Hartman, C. M. Walker, and S. A. Kalams
Analysis of the TCR {beta} Variable Gene Repertoire in Chimpanzees: Identification of Functional Homologs to Human Pseudogenes
J. Immunol., April 15, 2003; 170(8): 4161 - 4169.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. M. Addo, X. G. Yu, A. Rathod, D. Cohen, R. L. Eldridge, D. Strick, M. N. Johnston, C. Corcoran, A. G. Wurcel, C. A. Fitzpatrick, et al.
Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load
J. Virol., February 1, 2003; 77(3): 2081 - 2092.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Novitsky, H. Cao, N. Rybak, P. Gilbert, M. F. McLane, S. Gaolekwe, T. Peter, I. Thior, T. Ndung'u, R. Marlink, et al.
Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C
J. Virol., September 11, 2002; 76(20): 10155 - 10168.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
X. G. Yu, M. M. Addo, E. S. Rosenberg, W. R. Rodriguez, P. K. Lee, C. A. Fitzpatrick, M. N. Johnston, D. Strick, P. J. R. Goulder, B. D. Walker, et al.
Consistent Patterns in the Development and Immunodominance of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+ T-Cell Responses following Acute HIV-1 Infection
J. Virol., July 29, 2002; 76(17): 8690 - 8701.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Yusim, C. Kesmir, B. Gaschen, M. M. Addo, M. Altfeld, S. Brunak, A. Chigaev, V. Detours, and B. T. Korber
Clustering Patterns of Cytotoxic T-Lymphocyte Epitopes in Human Immunodeficiency Virus Type 1 (HIV-1) Proteins Reveal Imprints of Immune Evasion on HIV-1 Global Variation
J. Virol., July 29, 2002; 76(17): 8757 - 8768.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. M. Lauer, K. Ouchi, R. T. Chung, T. N. Nguyen, C. L. Day, D. R. Purkis, M. Reiser, A. Y. Kim, M. Lucas, P. Klenerman, et al.
Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities
J. Virol., May 13, 2002; 76(12): 6104 - 6113.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.